Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemostatic Effects of Clopidogrel and Ticagrelor With and Without ASA
NCT02120092Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Oct 2010
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ticagrelor in acute coronary syndrome (ACS) (4 arms), sponsored by Medical University of Vienna. Primary endpoint: beta-Thromboglobulin in shed blood at 2 hours. Started Oct 2010; status: completed.
02
Drugs
ticagrelor
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT02120092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02120092.